278 related articles for article (PubMed ID: 19349791)
1. Anti-VEGF therapeutic approaches for diabetic macular edema.
Khurana RN; Do DV; Nguyen QD
Int Ophthalmol Clin; 2009; 49(2):109-19. PubMed ID: 19349791
[No Abstract] [Full Text] [Related]
2. Anti-VEGF therapy in proliferative diabetic retinopathy.
Abdallah W; Fawzi AA
Int Ophthalmol Clin; 2009; 49(2):95-107. PubMed ID: 19349790
[No Abstract] [Full Text] [Related]
3. Comparative effectiveness of anti-growth factor therapies for diabetic macular edema: summary of primary findings and conclusions.
O'Malley PG
Arch Intern Med; 2012 Jul; 172(13):1014-5. PubMed ID: 22688778
[No Abstract] [Full Text] [Related]
4. Biological, preclinical and clinical characteristics of inhibitors of vascular endothelial growth factors.
Chong V
Ophthalmologica; 2012; 227 Suppl 1():2-10. PubMed ID: 22517120
[TBL] [Abstract][Full Text] [Related]
5. Review of anti-VEGF therapy in proliferative diabetic retinopathy.
Jardeleza MS; Miller JW
Semin Ophthalmol; 2009; 24(2):87-92. PubMed ID: 19373692
[TBL] [Abstract][Full Text] [Related]
6. Anti-vascular endothelial growth factor agents for diabetic maculopathy.
Salam A; DaCosta J; Sivaprasad S
Br J Ophthalmol; 2010 Jul; 94(7):821-6. PubMed ID: 19556214
[TBL] [Abstract][Full Text] [Related]
7. Selective and pan-blockade agents in the anti-angiogenic treatment of proliferative diabetic retinopathy: a literature summary.
Giuliari GP; Guel DA; Cortez MA; Cortez RT
Can J Ophthalmol; 2010 Oct; 45(5):501-8. PubMed ID: 20648074
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema.
Zehetner C; Kirchmair R; Huber S; Kralinger MT; Kieselbach GF
Br J Ophthalmol; 2013 Apr; 97(4):454-9. PubMed ID: 23385630
[TBL] [Abstract][Full Text] [Related]
9. Diabetic macular edema.
Lang GE
Ophthalmologica; 2012; 227 Suppl 1():21-9. PubMed ID: 22517122
[TBL] [Abstract][Full Text] [Related]
10. Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.
Rensch F; Spandau UH; Wickenhäuser A; Jonas JB
Acta Ophthalmol; 2010 Mar; 88(2):e36-7. PubMed ID: 19210330
[No Abstract] [Full Text] [Related]
11. Antivascular endothelial growth factor in diabetic retinopathy.
Iacono P; Battaglia Parodi M; Bandello F
Dev Ophthalmol; 2010; 46():39-53. PubMed ID: 20703031
[TBL] [Abstract][Full Text] [Related]
12. [Anti-VEGF therapy to treat diabetic macular edema].
Takamura Y
Nippon Ganka Gakkai Zasshi; 2014 Sep; 118(9):747-9. PubMed ID: 25318182
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.
Kumar V; Ghosh B; Raina UK; Goel N
Acta Ophthalmol; 2010 Mar; 88(2):e3; author reply e4. PubMed ID: 19549100
[No Abstract] [Full Text] [Related]
14. Evidence for anti-VEGF treatment of diabetic macular edema.
Bandello F; Berchicci L; La Spina C; Battaglia Parodi M; Iacono P
Ophthalmic Res; 2012; 48 Suppl 1():16-20. PubMed ID: 22907145
[TBL] [Abstract][Full Text] [Related]
15. The article by Kook et al 1 on the 1-year effect of bevacizumab in patients with chronic diffuse diabetic macular edema (DME).
Querques G
Retina; 2009 May; 29(5):718-9; author reply 719-20. PubMed ID: 19430285
[No Abstract] [Full Text] [Related]
16. Comparative effectiveness of anti-VEGF agents for diabetic macular edema.
Ollendorf DA; Colby JA; Pearson SD
Int J Technol Assess Health Care; 2013 Oct; 29(4):392-401. PubMed ID: 24290332
[TBL] [Abstract][Full Text] [Related]
17. Paracentesis before intravitreal injection of bevacizumab.
Tsui YP; Chiang CC; Tsai YY
Can J Ophthalmol; 2008 Apr; 43(2):239; author reply 239-40. PubMed ID: 18347632
[No Abstract] [Full Text] [Related]
18. Treatment of diabetic retinopathy with anti-VEGF drugs.
Waisbourd M; Goldstein M; Loewenstein A
Acta Ophthalmol; 2011 May; 89(3):203-7. PubMed ID: 21044274
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal anti-VEGF drugs as adjuvant therapy in diabetic retinopathy surgery.
Montero JA; Ruiz-Moreno JM; Correa ME
Curr Diabetes Rev; 2011 May; 7(3):176-84. PubMed ID: 21438852
[TBL] [Abstract][Full Text] [Related]
20. [Anti-VEGF inhibitors and their role in the treatment of diabetic macular oedema].
Kakkassery V; Winterhalter S; Joussen AM
Klin Monbl Augenheilkd; 2010 Sep; 227(9):701-11. PubMed ID: 20845250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
